iOS app Android app


What to Do About Disloyal Corporations

Robert Reich | Posted 12.06.2015 | Politics
Robert Reich

In 2013, Pfizer raked in nearly $4 billion on sales of the Prevnar 13 vaccine, which prevents diseases caused by pneumococcal bacteria, from ear infections to pneumonia -- for which Pfizer is the only manufacturer. Other countries wouldn't allow their patent systems to justify such huge charges. Neither should we -- especially when Pfizer stops being an American company.

Study Discovers New Way To Prevent Pneumonia In The Elderly

Reuters | Posted 04.26.2014 | Fifty

(Adds details on standard Pneumovax vaccine, updates share price, final two paragraphs) By Ransdell Pierson and Caroline Humer ...

FDA Approves Pneumonia Vaccine For Older Kids

Reuters | Posted 03.30.2013 | Healthy Living

Jan 25 (Reuters) - Pfizer Inc on Friday said U.S. regulators had approved wider use of its Prevnar 13 vaccine to prevent infections ...

Pneumonia Vaccine May Also Protect Ages 18 To 49, Trial Suggests

Reuters | Posted 12.04.2012 | Healthy Living

Oct 4 (Reuters) - Pfizer Inc said a late-stage trial of its vaccine to protect against pneumococcal bacteria suggested it would also...

CDC Recommends Expanded Use Of Vaccine Against Pneumococcal Disease

Reuters | Posted 08.20.2012 | Healthy Living

June 20 (Reuters) - An advisory committee for the U.S. Centers for Disease Control and Prevention on Wednesday voted to recommended expanded use of ...

One Lot Of Pneumococcal Vaccine Prevnar Recalled

AP | Posted 02.29.2012 | Healthy Living

NEW YORK -- Drugmaker Pfizer Inc. is recalling one lot of its blockbuster vaccine against pneumococcal disease, Prevnar 13. Pfizer says the lot is be...

FDA Approves Prevnar Pneumonia Vaccine

Reuters | Anna Yukhananov | Posted 02.29.2012 | Healthy Living

By Anna Yukhananov (Reuters) - U.S. health regulators approved the expansion of Pfizer Inc's blockbuster Prevnar vaccine for use in adul...

Prevnar Vaccine Works At Fighting Infection In Adults: FDA

AP | By MATTHEW PERRONE | Posted 01.14.2012 | Health News

WASHINGTON -- Federal health scientists say Pfizer's best-selling vaccine, Prevnar 13, is at least as effective as rival Merck's at helping prevent so...